BRIEF published on 04/02/2025 at 18:05, 1 year 5 months ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Actions Transparency Atlas Special Opportunities Oxurion Biopharmacy
PRESS RELEASE published on 04/02/2025 at 18:00, 1 year 5 months ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC waaruit blijkt verkoop van aandelen onder drempel. Meer informatie op www.oxurion.com Transparantiekennisgeving Oxurion NV Oftalmologische Therapieën Biofarmaceutisch Bedrijf Atlas Special Opportunities II LLC
PRESS RELEASE published on 04/02/2025 at 18:00, 1 year 5 months ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV, a biopharmaceutical company, received a transparency notification from Atlas Special Opportunities II, LLC regarding shareholding threshold crossing under Belgian legislation Transparency Notification Shareholding Threshold Oxurion NV Belgian Legislation Atlas Special Opportunities II LLC
BRIEF published on 03/27/2025 at 18:05, 1 year 5 months ago Oxurion reçoit une notification de transparence ajustée Actionnariat Notification De Transparence Oxurion Atlas Special Opportunities II Bourse De Bruxelles
BRIEF published on 03/27/2025 at 18:05, 1 year 5 months ago Oxurion receives adjusted transparency notification Transparency Notification Shareholding Oxurion Atlas Special Opportunities II Brussels Stock Exchange
PRESS RELEASE published on 03/27/2025 at 18:00, 1 year 5 months ago Oxurion ontvangt aangepaste transparantiekennisgeving van Atlas Special Opportunities II LLC Oxurion NV ontvangt aangepaste transparantiekennisgeving van Atlas Special Opportunities II LLC, waardoor zij onder de drempel (5%) komen. Meer informatie beschikbaar op www.oxurion.com Transparantiekennisgeving Oxurion NV Netvliesaandoeningen Biofarmaceutisch Bedrijf Atlas Special Opportunities II LLC
PRESS RELEASE published on 03/27/2025 at 18:00, 1 year 5 months ago Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV received an amended transparency notification from Atlas Special Opportunities II, LLC regarding the sale of voting securities. This press release replaces the one from March 18, 2025 Transparency Notification Euronext Brussels Oxurion NV Retinal Disease Therapies Atlas Special Opportunities II
BRIEF published on 03/24/2025 at 18:05, 1 year 5 months ago Oxurion Announces Capital Increase Following Convertible Bond Conversion Convertible Bonds Capital Increase Atlas Special Opportunities Ophthalmic Therapies Oxurion
BRIEF published on 03/24/2025 at 18:05, 1 year 5 months ago Oxurion annonce une augmentation de capital suite à la conversion d'obligations convertibles Obligations Convertibles Augmentation De Capital Thérapies Ophtalmiques Oxurion Opportunités Spéciales Atlas
PRESS RELEASE published on 03/24/2025 at 18:00, 1 year 5 months ago Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas Atlas Special Opportunities, LLC converts bonds in Oxurion, resulting in EUR 150,000 capital increase. Oxurion focuses on developing therapeutics for vision care Capital Increase Therapeutics Vision Care Atlas Special Opportunities LLC Oxurion
Published on 09/22/2026 at 23:10, 48 minutes ago Global Atomic Announces Proposed Public Offering of Units
Published on 09/22/2026 at 22:30, 1 hour 28 minutes ago Silver Spruce Receives TSXV Conditional Approval of Debt Settlement
Published on 09/22/2026 at 22:01, 1 hour 57 minutes ago Fermi and TensorWave Agree to Extend Closing Date to October 31, 2026
Published on 09/22/2026 at 21:40, 2 hours 18 minutes ago Sekur Private Data Launches Sekur.com in Portuguese in Preparation for Angola Launch
Published on 09/22/2026 at 17:00, 6 hours 58 minutes ago Leggett Dynamics Expands Asia Pacific Headquarters
Published on 09/22/2026 at 19:40, 4 hours 17 minutes ago EQS-Adhoc: Pyrum Innovations AG: Revision of the Forecast for the Financial Year 2026
Published on 09/22/2026 at 19:00, 4 hours 58 minutes ago LLB focuses on its "elevate" strategy for growth, excellence and resilience
Published on 09/22/2026 at 18:45, 5 hours 12 minutes ago MGI Digital Technology: Modification des ressources allouées au contrat de liquidité.
Published on 09/22/2026 at 18:30, 5 hours 27 minutes ago Avolta partners with Hawaii’s Department of Transportation to expand airport dining at three airports
Published on 09/22/2026 at 18:30, 5 hours 28 minutes ago Voyageurs du Monde: Communiqué sur le dépôt de projet de note en réponse (suite au dépôt de projet de note en réponse de Voyageurs du Monde à l'Autorité des Marchés Financiers)
Published on 09/22/2026 at 18:00, 5 hours 58 minutes ago Consolidated results for the first half of 2026 EBITDA : 60,5 M€
Published on 09/22/2026 at 18:00, 5 hours 58 minutes ago Résultats consolidés du premier semestre 2026 EBITDA : 60,5 M€
Published on 09/22/2026 at 17:45, 6 hours 13 minutes ago Imerys-09-2026-information-share-capital-and-voting-rights-as-of-31-August-2026
Published on 09/22/2026 at 17:45, 6 hours 13 minutes ago Imerys-09-2026-communique-capital-droits-de-vote-au-31-août-2026
